Microsoft Word - MDA Q319 EN.docx November 11, 2019 To President The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent
Page 1 of 4 No. RJH – SET 9/2020 10 August 2020 Subject : Management’s Discussion and Analysis for the Second Quarter of 2020 To : The President The Stock Exchange of Thailand Rajthanee Hospital
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
No. ADD 4/2022 23 February 2022 Subject: Management discussion and analysis for the performance of the year 2021 ended 31 December 2021 To: President The Stock Exchange of Thailand AddTech Hub Public
No. ADD 19/2022 11 May 2022 Subject: Management discussion and analysis for the performance for the three-month period ended 31 March 2022 To: President The Stock Exchange of Thailand AddTech Hub
No. ADD 11/2023 11 May 2023 Subject: Management discussion and analysis for the performance for the three-month period ended 31 March 2023 To: President The Stock Exchange of Thailand AddTech Hub
No. ADD 3/2024 22 February 2024 Subject: Management discussion and analysis for the performance for the year ended 31 December 2023 To: President The Stock Exchange of Thailand AddTech Hub Public
No. ADD 12/2024 10 May 2024 Subject: Management discussion and analysis for the performance for the three-month period ended 31 March 2024 To: President The Stock Exchange of Thailand AddTech Hub
% Net Profit for the company 29 63 117% 60 123 105% Gross profit margin (%) 67.0% 64.4% (2.6%) 67.4% 64.9% (2.5%) EBITDA margin (%) 23.2% 30.2% 7.0% 24.1% 30.7% 6.6% Net profit margin (%) 13.9% 20.0% 6.1
as the definition of “institutional investor” under Section 3 of the Derivatives Act B.E. 2546 (2003) and related notifications issued by virtue of such law; “margin account” means an account which